Randomized, open label, controlled clinical trial of eldcalcitol for falls prevention in postmenopausal osteoporotic patients with depression.
Not Applicable
- Conditions
- Falls
- Registration Number
- JPRN-UMIN000011670
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
none
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are diagnosed as contraindication of raloxifene treatments Patients who are diagnosed as contraindication of eldecalcitol treatments Patient who have a past history of treatment with vitamin D within 6 months Patient who have a past history of treatment for osteoporosis besides vitamin D in the past 12-months Unsuitable for trial as evaluated by the physician-in-charge Subject who refuse to participate in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Falls rate
- Secondary Outcome Measures
Name Time Method falls related injury Hamilton raing scale for depression physical function bone mineral density mauscle volume markers of bone metabolism falls efficacy scale